We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look ...

Dr. Naomi Wolf spoke at an India Today event about her book 'The Pfizer Papers', which examines internal Pfizer documents on COVID-19 vaccine development. She alleges the company knew of serious side ...

Wolf, who stated that she is not vaccinated against Covid-19, claimed that live birth rates have dropped by 13-20%, ...

Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

In a report released today, Kerry Holford from Berenberg Bank maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, describes how his company's ...

The Patent Trial and Appeal Board agreed with Pfizer and its German partner that Moderna's patents were invalid based on "prior art" that disclosed the inventions before Moderna patented them. The ...

Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.

Moderna (MRNA) stock is climbing 8% after the drug maker won a key court case and its CEO bought shares on the open market.

Uniondale-based McHugh Furnishings, a provider of specialty furnishings for education, healthcare, entertainment and ...